Senate Committee on Health, Education, Labor and Pensions (HELP): “Lower Health Care Costs Act”
Tuesday, June 18, 2019: The Senate Committee on Health, Education, Labor and Pensions (HELP) held a hearing on the Lower Health Care Costs Act, a bipartisan discussion draft largely concerning drug pricing. The committee requested comment on the draft that


Senate Committee on the Judiciary: “The State of Patent Eligibility in America: Part III”

Tuesday, June 11, 2019: The Senate Judiciary’s Subcommittee on Intellectual Property held a hearing continuing its work on patent eligibility, with a large panel of witnesses, most of whom are arguing in favor of statutory reform that would tighten up


House Energy & Commerce, Subcommittee on Health: “Investing in America’s Healthcare”

The Health Subcommittee of the Committee on Energy and Commerce held a hearing on health care extenders, discussing the following legislation:

  • H.R. 1767, the “Excellence in Mental Health and Addiction Treatment Expansion Act”
  • H.R. 1943, the “Community Health Center and Primary

McGuireWoods Consulting senior vice president, Stephanie Kennan, commented on the U.S. Supreme Court decision in a recent Medicare reimbursement case in a June 3 article for Inside Health Policy.

The court rejected Centers for Medicaid and Medicare Services’ (CMS) argument that it had broad authority to issue its own legal interpretations of the

As Congress focuses on how to drive down drug prices, there is bipartisan support for prohibiting reverse payment agreements, also known as “pay-for-delay” arrangements. These arrangements involve a brand-name pharmaceutical manufacturer paying one or more potential generic competitors to delay bringing a generic to market as part of a resolution to a patent infringement lawsuit.

Stethoscope on laptop keyboard


Senate Judiciary Committee: “Intellectual Property and the Price of Prescription Drugs: Balancing Innovation and Competition”
Tuesday, May 7, 2019: The Senate Judiciary Committee held a hearing on practices by drug manufacturers to delay the patent system and extend monopolies on prescription drugs. Find witness testimonies, live feed and other information here.

Why this is

This week in Washington: Hearings continue on the price of prescription drugs, Senate Committee on Finance to hold a hearing on Medicare physician payment reform, while the Senate HELP Committee will hold its second hearing in a series on electronic health information and further implementing the 21st Century Cures Act.


House Committee on Rules:


House Judiciary Committee: “TBA Markup on CREATES Act, Pay-for-Delay Legislation”
The House Judiciary Committee is planning a markup on the CREATES Act and pay-for-delay legislation. The date of the markup is to be announced. Last month, Judiciary Committee Chair Jerrold Nadler (D-NY) said he intended to introduce a bill to prohibit deals in which


Senate Finance Committee: “Drug Pricing in America: A Prescription for Change, Part III”
Tuesday, April 9, 2019: The Senate Finance Committee continued its drug pricing series by inviting pharmacy benefit manager companies (PBMs) to testify before the committee. The invitation was extended on March 12 to Cigna, CVS Caremark and CVS Health, Humana, OptumRx